A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma
Figure 4.Construction of predictive risk model in glioma patients. (A–C) The two risk groups risk in the three cohorts. (D–F) The survival status of glioma patients. (G–I) The heatmap of 9 NRLs. (J–L) The Kaplan-Meier analysis.